FTC lice Internet surf
This article was originally published in The Tan Sheet
Executive Summary
Twenty-eight Web sites advertising lice treatment products were identified during a surf conducted by FTC's Division of Enforcement and Western Regional Office, the commission announces April 11. Many claims, such as "100% effective in killing lice and their eggs" and "eliminate the need for combing," may be misleading, FTC notes. While no enforcement actions have been taken, the agency has sent letters to the companies reminding them claims need adequate substantiation. The surf follows up on settlements FTC reached with Del Pharmaceuticals, Pfizer and Care Technologies regarding allegedly deceptive advertising claims made for their pediculicides (1"The Tan Sheet" Jan. 4, 1999, In Brief)
You may also be interested in...
FTC orders with Del, Pfizer, Care Technologies
Give final approval to separate consent orders regarding Del's Pronto shampoo, Pfizer's RID shampoo and egg removal comb and Care Technologies' Clear shampoo and lice egg remover to settle allegations the companies made false and unsubstantiated claims for the OTC head lice treatments. Proposed in September, the orders require that for two years, whenever a claim is made regarding product efficacy, the marketers include a disclosure about the necessity of a second treatment application ("The Tan Sheet" Sept. 28, 1998, p. 22). While the commission vote to make the orders final was unanimous, Commissioner Orson Swindle reiterated his concern about the disclosure requirement. The order against Del also prohibits claims about the extent to which health care professionals recommend Baby Orajel
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands